Integra Lifesciences Holdings Corp financial data

Symbol
IART on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1100 Campus Road, Princeton, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
INTEGRA LIFESCIENCES CORP (to 3/31/1999)
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 253 % -20.7%
Quick Ratio 89.3 % -14.6%
Debt-to-equity 156 % +25.4%
Return On Equity -0.42 % -107%
Return On Assets -0.16 % -106%
Operating Margin 1.84 % -80.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77.2M shares -1.3%
Entity Public Float 3.26B USD -16.8%
Common Stock, Value, Issued 916K USD +0.77%
Weighted Average Number of Shares Outstanding, Basic 76.4M shares -4.07%
Weighted Average Number of Shares Outstanding, Diluted 76.4M shares -4.21%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.56B USD +1.45%
Costs and Expenses 1.54B USD +9.78%
Operating Income (Loss) 28.8M USD -79.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.9M USD -110%
Income Tax Expense (Benefit) -5.38M USD -135%
Net Income (Loss) Attributable to Parent -6.54M USD -106%
Earnings Per Share, Basic -0.08 USD/shares -106%
Earnings Per Share, Diluted -0.08 USD/shares -107%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 215M USD -21.4%
Accounts Receivable, after Allowance for Credit Loss, Current 248M USD -3.11%
Inventory, Net 437M USD +19.3%
Other Assets, Current 50.4M USD
Assets, Current 1.1B USD +7.04%
Deferred Income Tax Assets, Net 48.9M USD -12%
Property, Plant and Equipment, Net 391M USD +22.6%
Operating Lease, Right-of-Use Asset 146M USD -6.65%
Intangible Assets, Net (Excluding Goodwill) 1.21B USD +13.4%
Goodwill 1.12B USD +7.76%
Other Assets, Noncurrent 54M USD -30.7%
Assets 4.07B USD +8.73%
Employee-related Liabilities, Current 76.4M USD +19.7%
Accrued Liabilities, Current 132M USD +46.1%
Contract with Customer, Liability, Current 9.99M USD +22.7%
Liabilities, Current 913M USD +157%
Contract with Customer, Liability, Noncurrent 8.1M USD 0%
Deferred Income Tax Liabilities, Net 68.9M USD -7.4%
Operating Lease, Liability, Noncurrent 168M USD -0.12%
Other Liabilities, Noncurrent 190M USD +33.3%
Liabilities 2.54B USD +17.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -24.9M USD -1524%
Retained Earnings (Accumulated Deficit) 920M USD -0.71%
Stockholders' Equity Attributable to Parent 1.52B USD -3.65%
Liabilities and Equity 4.07B USD +8.73%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 15.8M USD -39.8%
Net Cash Provided by (Used in) Financing Activities 359M USD
Net Cash Provided by (Used in) Investing Activities -54M USD -294%
Common Stock, Shares Authorized 240M shares 0%
Common Stock, Shares, Issued 91.6M shares +0.72%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 316M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 215M USD -21.4%
Deferred Tax Assets, Valuation Allowance 12.5M USD +29.4%
Deferred Tax Assets, Gross 240M USD +13.8%
Operating Lease, Liability 183M USD +0.2%
Payments to Acquire Property, Plant, and Equipment 15.5M USD +12.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -33.1M USD -130%
Lessee, Operating Lease, Liability, to be Paid 270M USD -1.96%
Property, Plant and Equipment, Gross 708M USD +10.4%
Operating Lease, Liability, Current 15M USD +4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 21.6M USD +1.64%
Lessee, Operating Lease, Liability, to be Paid, Year One 23.3M USD +5.4%
Deferred Income Tax Expense (Benefit) -2.86M USD -246%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 87.3M USD -6.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.7M USD +6.93%
Deferred Tax Assets, Operating Loss Carryforwards 28.8M USD -6.21%
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 812K USD +13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.5M USD -4.06%
Operating Lease, Payments 5.73M USD +32.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 20.6M USD +59.9%
Deferred Tax Assets, Net of Valuation Allowance 227M USD +13%
Interest Expense 52.9M USD +5.72%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares